2Young Xu Y,Jabbour S,Goldberg R,et al.Usefulness of stain drugs in protecting against fibrillation in patients with coronary artery disease[J].Am J Cardiol,2003;92(12):1379-83.
3Siu CM,Lau CP,Tse HF.Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion[J].Am J Cardiol,2003;92(11):1343-5.
4Libby P,Aikawa M,Mechanisms of plaque stabilization with statins[J].Am J Cardiol,2003;91(4A):4B-8B.
6Vasa M,Fichtlscherer S,Adler K,et al.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease[J].Circulation,2001;103(24):1885-90.
2DAVIDSON MH.Controversy surrounding the safety of cerivastatin[J].Expert Opin Drug Saf,2002,1 (3):207-212.
3STAFFA JA,CHANG J,GREEN L.Cerivastatin and reports of fatal rhabdomyolysis[J].N Engl J Med,2002,346(7):539-540.
4RATZBRAVO AE,TCHAMBAZ L,KRAHENBUHL-MELCHER A,et al.Prevalence of potentially severe drug-drug interaction in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy[J].Drug Saf,2005,28 (3):203-275.
5BELLOSTA S,PAOLETTI R,CORSINI A,et al.Safety of statins:focus on clinical pharmacokinetics and drug interactions[J].Circulation,2004,109(23 Suppl 1):Ⅲ 50-Ⅲ 57.
6KAJINAMI K,TAKEKOSHI N,SAITO YL.Pitavastatin:efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor[J].Cardiovasc Drug Rev,2003,21 (3):199-215.
7McKENNEY JM.Efficacy and safety of rosuvastatin in treatment of dyslipidemia[J].Am J Health Syst Pharm,2005,62(10):1033-1047.
3Mathew JP,Parks R,Savino JS,et al.Atrial fibrillation following coronary artery bypass graft surgery:predictors,outcomes and resource utilization.JAMA 1996;276:300-306.
4Stamou SC,Dangas G,Dullum MKC,et al.Beating heart surgery in octogenarians:perioperative outcome and comparison with younger age groups.Ann Thorac Surg,2000,69:1140-1145.
5Joseph P,Manuel L,Iulia C,et al.A multicenter risk index for atrial fibrillation after cardiac surgery.JAMA,2004,291:1720-1729.
6Valentin Fuster,Lars E.Ryden,et al.ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation:Executive Summary.Circulation,2001,104:2118-2150.
